Drug Trial Radar · NCT01731093
Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
Last checked: Nov 19, 2026Latest source record: Jan 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Mar 2012
Primary completion
Oct 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- Alltech Life Sciences Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 21, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety, bioavailability, and effectiveness of an organic yeast-selenium compound in reducing brain oxidative stress. Oxidative stress in the brain has been linked to a variety oif disorders including Alzheimer's disease. Selenium is a very powerful antioxidant that could prove useful in reducing the harmful effects of oxidative stress in the brain and may help prevent diseases such as Alzheimer's. Our recent work has demonstrated that the specific type of selenium compound greatly influences it's ability to enhance brain health and prevent Alzheimer changes in mouse models of this disease. This study will enroll 24 participants and will allow us to test the hypotheses that yeast-selenium supplementation is safe in the elderly, and that our specific formulation reduces brain oxidative stress.
Conditions
- Oxidative Stress
Interventions
AT-001Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of adverse eventsTime frame: Baseline to week 14
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Kentucky Alzheimer's Disease Research Center
Lexington, Kentucky
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.